The authors propose conducting a scenario analysis for interventions to treat rare diseases by varying health plan size to demonstrate the variability of potential budget impact. Scenario analyses of ...

Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab. Objectives: ...

A new analysis from the Office of the Actuary at the Centers for Medicare and Medicaid Services (CMS) estimates that in 2021 health care spending in the United States increased 2.7 percent to $4.3 ...

The 2021 Federal Budget was handed down on Tuesday night, but there was much to talk about the morning after. Look, no one can say WHEN the pandemic will end, but political reporter Tom Lowry's piece ...